133 related articles for article (PubMed ID: 11590838)
1. The pathobiology of pulmonary hypertension. Smooth muscle cells and ion channels.
Michelakis ED; Weir EK
Clin Chest Med; 2001 Sep; 22(3):419-32. PubMed ID: 11590838
[TBL] [Abstract][Full Text] [Related]
2. Preferential expression and function of voltage-gated, O2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells.
Archer SL; Wu XC; Thébaud B; Nsair A; Bonnet S; Tyrrell B; McMurtry MS; Hashimoto K; Harry G; Michelakis ED
Circ Res; 2004 Aug; 95(3):308-18. PubMed ID: 15217912
[TBL] [Abstract][Full Text] [Related]
3. Molecular identification of the role of voltage-gated K+ channels, Kv1.5 and Kv2.1, in hypoxic pulmonary vasoconstriction and control of resting membrane potential in rat pulmonary artery myocytes.
Archer SL; Souil E; Dinh-Xuan AT; Schremmer B; Mercier JC; El Yaagoubi A; Nguyen-Huu L; Reeve HL; Hampl V
J Clin Invest; 1998 Jun; 101(11):2319-30. PubMed ID: 9616203
[TBL] [Abstract][Full Text] [Related]
4. In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically hypoxic rats.
Pozeg ZI; Michelakis ED; McMurtry MS; Thébaud B; Wu XC; Dyck JR; Hashimoto K; Wang S; Moudgil R; Harry G; Sultanian R; Koshal A; Archer SL
Circulation; 2003 Apr; 107(15):2037-44. PubMed ID: 12695303
[TBL] [Abstract][Full Text] [Related]
5. The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension.
Moudgil R; Michelakis ED; Archer SL
Microcirculation; 2006 Dec; 13(8):615-32. PubMed ID: 17085423
[TBL] [Abstract][Full Text] [Related]
6. Role of K+ channels in pulmonary hypertension.
Mandegar M; Yuan JX
Vascul Pharmacol; 2002 Jan; 38(1):25-33. PubMed ID: 12378819
[TBL] [Abstract][Full Text] [Related]
7. Ion channels in pulmonary arterial hypertension.
Mandegar M; Remillard CV; Yuan JX
Prog Cardiovasc Dis; 2002; 45(2):81-114. PubMed ID: 12411972
[TBL] [Abstract][Full Text] [Related]
8. Molecular identification of O2 sensors and O2-sensitive potassium channels in the pulmonary circulation.
Archer SL; Weir EK; Reeve HL; Michelakis E
Adv Exp Med Biol; 2000; 475():219-40. PubMed ID: 10849663
[TBL] [Abstract][Full Text] [Related]
9. Pathology and pathobiology of pulmonary hypertension.
Guignabert C; Dorfmuller P
Semin Respir Crit Care Med; 2013 Oct; 34(5):551-9. PubMed ID: 24037624
[TBL] [Abstract][Full Text] [Related]
10. [Properties of potassium channels in pulmonary arterial smooth muscle cells in hypoxic pulmonary hypertension].
Chen W
Zhonghua Nei Ke Za Zhi; 1997; 36(1):5-6. PubMed ID: 9812551
[No Abstract] [Full Text] [Related]
11. Chronic hypoxia-induced pulmonary hypertension does/does not lead to loss of pulmonary vasculature.
Berg JT
J Appl Physiol (1985); 2007 Oct; 103(4):1455. PubMed ID: 17916681
[No Abstract] [Full Text] [Related]
12. Subacute hypoxia decreases voltage-activated potassium channel expression and function in pulmonary artery myocytes.
Hong Z; Weir EK; Nelson DP; Olschewski A
Am J Respir Cell Mol Biol; 2004 Sep; 31(3):337-43. PubMed ID: 15151918
[TBL] [Abstract][Full Text] [Related]
13. The Action of Smooth Muscle Cell Potassium Channels in the Pathology of Pulmonary Arterial Hypertension.
Hayabuchi Y
Pediatr Cardiol; 2017 Jan; 38(1):1-14. PubMed ID: 27826710
[TBL] [Abstract][Full Text] [Related]
14. Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels.
Michelakis ED; McMurtry MS; Wu XC; Dyck JR; Moudgil R; Hopkins TA; Lopaschuk GD; Puttagunta L; Waite R; Archer SL
Circulation; 2002 Jan; 105(2):244-50. PubMed ID: 11790708
[TBL] [Abstract][Full Text] [Related]
15. Cellular and molecular pathobiology of pulmonary arterial hypertension.
Humbert M; Morrell NW; Archer SL; Stenmark KR; MacLean MR; Lang IM; Christman BW; Weir EK; Eickelberg O; Voelkel NF; Rabinovitch M
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):13S-24S. PubMed ID: 15194174
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension.
Mandegar M; Fung YC; Huang W; Remillard CV; Rubin LJ; Yuan JX
Microvasc Res; 2004 Sep; 68(2):75-103. PubMed ID: 15313118
[TBL] [Abstract][Full Text] [Related]
17. Key role of 15-lipoxygenase/15-hydroxyeicosatetraenoic acid in pulmonary vascular remodeling and vascular angiogenesis associated with hypoxic pulmonary hypertension.
Ma C; Li Y; Ma J; Liu Y; Li Q; Niu S; Shen Z; Zhang L; Pan Z; Zhu D
Hypertension; 2011 Oct; 58(4):679-88. PubMed ID: 21859965
[TBL] [Abstract][Full Text] [Related]
18. Patho-, physiological roles of voltage-dependent K+ channels in pulmonary arterial smooth muscle cells.
Park WS; Firth AL; Han J; Ko EA
J Smooth Muscle Res; 2010; 46(2):89-105. PubMed ID: 20551590
[TBL] [Abstract][Full Text] [Related]
19. The pathobiology of pulmonary hypertension. Endothelium.
Tuder RM; Cool CD; Yeager M; Taraseviciene-Stewart L; Bull TM; Voelkel NF
Clin Chest Med; 2001 Sep; 22(3):405-18. PubMed ID: 11590837
[TBL] [Abstract][Full Text] [Related]
20. Oxygen-sensing potassium currents in pulmonary artery.
McCulloch KM; Osipenko ON; Gurney AM
Gen Pharmacol; 1999 Apr; 32(4):403-11. PubMed ID: 10323480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]